Zinc in PDB 5sfx: Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide, PDB code: 5sfx
was solved by
C.Joseph,
A.Flohr,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.72 /
2.04
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.943,
135.943,
235.595,
90,
90,
120
|
R / Rfree (%)
|
17.7 /
22.3
|
Other elements in 5sfx:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide
(pdb code 5sfx). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide, PDB code: 5sfx:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sfx
Go back to
Zinc Binding Sites List in 5sfx
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:32.3
occ:1.00
|
OD2
|
A:ASP564
|
2.1
|
30.3
|
1.0
|
NE2
|
A:HIS563
|
2.1
|
25.5
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
28.5
|
1.0
|
OD1
|
A:ASP674
|
2.1
|
29.9
|
1.0
|
O
|
A:HOH972
|
2.2
|
25.1
|
1.0
|
O
|
A:HOH950
|
2.2
|
32.1
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
27.3
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
26.1
|
1.0
|
CG
|
A:ASP674
|
3.1
|
30.3
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
27.7
|
1.0
|
CG
|
A:ASP564
|
3.1
|
28.3
|
1.0
|
CE1
|
A:HIS563
|
3.2
|
27.7
|
1.0
|
OD2
|
A:ASP674
|
3.4
|
32.9
|
1.0
|
OD1
|
A:ASP564
|
3.7
|
25.6
|
1.0
|
MG
|
A:MG802
|
3.7
|
27.0
|
1.0
|
CG
|
A:HIS563
|
4.1
|
25.9
|
1.0
|
CD2
|
A:HIS525
|
4.2
|
31.8
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
28.0
|
1.0
|
O
|
A:HOH992
|
4.2
|
25.1
|
1.0
|
ND1
|
A:HIS563
|
4.2
|
29.0
|
1.0
|
CG
|
A:HIS529
|
4.2
|
27.4
|
1.0
|
CB
|
A:ASP564
|
4.2
|
26.8
|
1.0
|
O
|
A:HOH956
|
4.4
|
30.4
|
1.0
|
NE2
|
A:HIS525
|
4.4
|
28.7
|
1.0
|
CB
|
A:ASP674
|
4.4
|
28.0
|
1.0
|
O
|
A:HOH921
|
4.6
|
23.9
|
1.0
|
CG2
|
A:VAL533
|
4.7
|
26.5
|
1.0
|
O
|
A:HOH1015
|
4.8
|
53.1
|
1.0
|
O
|
A:ASP674
|
4.8
|
29.0
|
1.0
|
CA
|
A:ASP674
|
4.9
|
26.6
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sfx
Go back to
Zinc Binding Sites List in 5sfx
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:30.7
occ:1.00
|
OD1
|
B:ASP674
|
2.1
|
26.3
|
1.0
|
NE2
|
B:HIS563
|
2.1
|
22.7
|
1.0
|
OD2
|
B:ASP564
|
2.1
|
23.9
|
1.0
|
O
|
B:HOH964
|
2.2
|
23.7
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
23.5
|
1.0
|
O
|
B:HOH985
|
2.2
|
31.2
|
1.0
|
CG
|
B:ASP674
|
3.0
|
28.8
|
1.0
|
CD2
|
B:HIS563
|
3.1
|
24.6
|
1.0
|
CD2
|
B:HIS529
|
3.1
|
26.7
|
1.0
|
CE1
|
B:HIS563
|
3.2
|
23.0
|
1.0
|
CG
|
B:ASP564
|
3.2
|
26.6
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
27.9
|
1.0
|
OD2
|
B:ASP674
|
3.3
|
26.4
|
1.0
|
OD1
|
B:ASP564
|
3.7
|
26.3
|
1.0
|
MG
|
B:MG802
|
3.8
|
27.3
|
1.0
|
O
|
B:HOH984
|
4.1
|
23.5
|
1.0
|
CD2
|
B:HIS525
|
4.1
|
29.1
|
1.0
|
CG
|
B:HIS563
|
4.2
|
24.0
|
1.0
|
ND1
|
B:HIS563
|
4.2
|
24.7
|
1.0
|
CG
|
B:HIS529
|
4.3
|
23.8
|
1.0
|
O
|
B:HOH941
|
4.3
|
30.2
|
1.0
|
CB
|
B:ASP564
|
4.3
|
24.1
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
25.3
|
1.0
|
NE2
|
B:HIS525
|
4.4
|
33.7
|
1.0
|
CB
|
B:ASP674
|
4.4
|
26.0
|
1.0
|
O
|
B:HOH947
|
4.6
|
25.1
|
1.0
|
CG2
|
B:VAL533
|
4.7
|
21.7
|
1.0
|
O
|
B:HOH1029
|
4.7
|
51.5
|
1.0
|
CA
|
B:ASP674
|
4.9
|
25.4
|
1.0
|
O
|
B:ASP674
|
4.9
|
26.8
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sfx
Go back to
Zinc Binding Sites List in 5sfx
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:32.1
occ:1.00
|
NE2
|
C:HIS529
|
2.1
|
28.2
|
1.0
|
O
|
C:HOH937
|
2.1
|
25.4
|
1.0
|
OD2
|
C:ASP564
|
2.2
|
28.9
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
26.2
|
1.0
|
NE2
|
C:HIS563
|
2.3
|
25.9
|
1.0
|
O
|
C:HOH1001
|
2.3
|
39.0
|
1.0
|
CD2
|
C:HIS529
|
3.0
|
30.4
|
1.0
|
CG
|
C:ASP674
|
3.0
|
31.5
|
1.0
|
CD2
|
C:HIS563
|
3.0
|
27.4
|
1.0
|
CG
|
C:ASP564
|
3.1
|
29.0
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
32.3
|
1.0
|
OD2
|
C:ASP674
|
3.2
|
34.5
|
1.0
|
CE1
|
C:HIS563
|
3.3
|
25.2
|
1.0
|
OD1
|
C:ASP564
|
3.7
|
27.0
|
1.0
|
MG
|
C:MG802
|
3.8
|
27.1
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
33.0
|
1.0
|
CG
|
C:HIS529
|
4.2
|
26.2
|
1.0
|
O
|
C:HOH1003
|
4.2
|
25.5
|
1.0
|
CG
|
C:HIS563
|
4.2
|
27.5
|
1.0
|
ND1
|
C:HIS529
|
4.2
|
27.1
|
1.0
|
CB
|
C:ASP564
|
4.3
|
27.6
|
1.0
|
O
|
C:HOH987
|
4.3
|
36.7
|
1.0
|
ND1
|
C:HIS563
|
4.4
|
26.9
|
1.0
|
CB
|
C:ASP674
|
4.4
|
28.6
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
34.6
|
1.0
|
O
|
C:HOH947
|
4.6
|
29.9
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
28.1
|
1.0
|
O
|
C:HOH1021
|
4.8
|
46.5
|
1.0
|
CA
|
C:ASP674
|
4.8
|
30.6
|
1.0
|
O
|
C:ASP674
|
4.9
|
30.5
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sfx
Go back to
Zinc Binding Sites List in 5sfx
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with N-(2- Acetamido-1,3-Benzothiazol-5-Yl)-4-(Azetidine-1-Carbonyl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:36.9
occ:1.00
|
O
|
D:HOH912
|
2.0
|
31.1
|
1.0
|
NE2
|
D:HIS563
|
2.1
|
27.3
|
1.0
|
OD2
|
D:ASP564
|
2.2
|
35.3
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
34.9
|
1.0
|
OD1
|
D:ASP674
|
2.2
|
33.5
|
1.0
|
O
|
D:HOH966
|
2.2
|
37.8
|
1.0
|
CD2
|
D:HIS563
|
2.9
|
28.8
|
1.0
|
CD2
|
D:HIS529
|
3.0
|
35.7
|
1.0
|
CG
|
D:ASP564
|
3.1
|
29.2
|
1.0
|
CG
|
D:ASP674
|
3.1
|
35.7
|
1.0
|
CE1
|
D:HIS529
|
3.3
|
37.2
|
1.0
|
OD2
|
D:ASP674
|
3.3
|
35.4
|
1.0
|
CE1
|
D:HIS563
|
3.3
|
33.2
|
1.0
|
OD1
|
D:ASP564
|
3.6
|
33.8
|
1.0
|
MG
|
D:MG802
|
3.8
|
36.6
|
1.0
|
CD2
|
D:HIS525
|
4.1
|
41.1
|
1.0
|
CG
|
D:HIS563
|
4.1
|
29.5
|
1.0
|
O
|
D:HOH942
|
4.2
|
36.7
|
1.0
|
O
|
D:HOH953
|
4.2
|
30.6
|
1.0
|
CG
|
D:HIS529
|
4.2
|
31.8
|
1.0
|
CB
|
D:ASP564
|
4.2
|
30.9
|
1.0
|
ND1
|
D:HIS529
|
4.3
|
30.6
|
1.0
|
ND1
|
D:HIS563
|
4.3
|
28.4
|
1.0
|
NE2
|
D:HIS525
|
4.4
|
47.7
|
1.0
|
CB
|
D:ASP674
|
4.4
|
30.2
|
1.0
|
O
|
D:HOH911
|
4.6
|
31.0
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
38.4
|
1.0
|
O
|
D:ASP674
|
4.8
|
29.0
|
1.0
|
CA
|
D:ASP674
|
4.9
|
29.8
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 05:04:36 2024
|